The organization noted that US senators have introduced a bill to accelerate Medicare coverage for breakthrough devices.

The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

Ospri specializes in PCR-based infectious disease detection and is financed by up to $30 million of strategic funding from Catalio Capital Management.